Kanagawa, Japan

Naoko Ueda

This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Chemical Corporation. Active years: 1998-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoko Ueda. Retrieved from https://idiyas.com/inventor/naoko-ueda-ggilrk66

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoko Ueda: Innovator in Antiviral Compounds

Introduction

Naoko Ueda is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of antiviral agents, holding a total of 2 patents. Her work focuses on developing compounds that can provide effective treatments for viral infections.

Latest Patents

Among her latest patents is a phosphonate nucleotide compound, which is represented by a specific formula. This compound exhibits antiviral activity and is designed to be an orally available and highly safe antiviral agent. The detailed structure of the compound includes various substituents that enhance its efficacy against viruses.

Career Highlights

Naoko Ueda is affiliated with Mitsubishi Chemical Corporation, where she continues to innovate and develop new pharmaceutical solutions. Her research has been pivotal in advancing the understanding of antiviral compounds and their applications in medicine.

Collaborations

She has collaborated with notable colleagues, including Masaru Ubasawa and Kouichi Sekiya, to further her research and development efforts in the field of antiviral agents.

Conclusion

Naoko Ueda's contributions to the field of antiviral compounds highlight her role as a leading inventor in the pharmaceutical industry. Her innovative work continues to pave the way for new treatments that can benefit public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…